| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.5 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.032 | 0.6 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.033 | 0.6 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.6 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.6 |
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | 0.023 | 0.6 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.032 | 0.6 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.027 | 0.6 |